SUKH DEV SINGH KHALSA: Open Payments
NPI 1881978682 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 24 payments from 7 companies in 2025. Trend: 2023 $78 · 2024 $55 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $167 |
| Alkermes, Inc. | 10 | $156 |
| ABBVIE INC. | 4 | $86 |
| Bausch Health US, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, APLENZIN, ABILIFY MAINTENA, Xelstrym, COBENFY.
Industry payments across KY — which companies pay providers there.
